Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoHKSE:02279 +5.51%84 Current Ratio is 1.63 as of Jun. 2026, which is 29% above its 10-year median of 1.26. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 54.25% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Yonghe Medical Group Co's current ratio for the quarter that ended in Jun. 2026 was 1.63.
Yonghe Medical Group Co has a current ratio of 1.63. It generally indicates good short-term financial strength.
The historical rank and industry rank for Yonghe Medical Group Co's Current Ratio or its related term are showing as below:
HKSE:02279'
s Current Ratio Range Over the Past 10 Years
Min: 0.64 Med: 1.26 Max: 3.05
Current: 1.63
During the past 8 years, Yonghe Medical Group Co's highest Current Ratio was 3.05. The lowest was 0.64. And the median was 1.26.
HKSE:02279's Current Ratio is ranked better than 54.25% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.46
vs HKSE:02279: 1.63
Yonghe Medical Group Co (HKSE:02279) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Yonghe Medical Group Co Current Ratio Related Terms
Yonghe Medical Group Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02279 vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co (HKSE:02279) has a Current Ratio of 1.63 as of Jun. 2026. This is 29% above median its historical median of 1.26. Over the past decade, Yonghe Medical Group Co's Current Ratio has ranged from 0.64 to 3.05. According to the industry distribution chart, Yonghe Medical Group Co ranks #312 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Yonghe Medical Group Co's Current Ratio too high?
Yonghe Medical Group Co's current Current Ratio of 1.63 is 29% above median its 10-year median of 1.26. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 3.05. The Healthcare Providers & Services industry median Current Ratio is 1.46. Yonghe Medical Group Co's value of 1.63 is 11.6% above this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #312 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #312 out of 682 companies for Current Ratio. This puts Yonghe Medical Group Co in the upper half of its industry. The industry median Current Ratio is 1.46. Yonghe Medical Group Co's value of 1.63 is 11.6% above this benchmark. Historically, Yonghe Medical Group Co's own Current Ratio has ranged from 0.64 to 3.05 over the past decade. While the company's 10-year median is 1.26 vs. the industry median of 1.46, Yonghe Medical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.46, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current Current Ratio of 1.63 is 11.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current Current Ratio is 1.63, which is 29% above median its own 10-year median of 1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current Current Ratio is 1.63, which is 29% above median its 10-year median of 1.26 and 11.6% above the Healthcare Providers & Services industry median of 1.46. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current Current Ratio is 1.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01.
GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.
Key valuation signals for HKSE:02279:
Current Ratio: 1.63 (29% above median its 10-year median of 1.26)
GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
Industry Position: 11.6% above the Healthcare Providers & Services median (#312 of 682)
No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for HKSE:02279
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02279 has been successfully added to your 
